Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Zydus Lifesciences Limited
Press Release Mar 03 2023
Business
Mar 3 2023
3 min read

Press Release Mar 03 2023

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 03, 2023, titled "Zydus receives final approval from the USFDA for Vigabatrin for Oral Solution USP, 500 mg".

View Attachment